TOMDF / Todos Medical updates investors on its lab Provista Diagnostics, subsidiary 3CL Pharma, and Todos Botanicals automated retail rollout

Todos Medical Ltd. (OTCQB:TOMDF) announced it has entered into a letter of intent (LOI) with Acumen Diagnostics of Singapore for its CLIA/CAP-certifi more_horizontal

Todos Medical Ltd CEO Gerald Commissiong has shared the company's aim to open a prospective study to confirm the usefulness of its dietary supplement more_horizontal

Todos Medical Ltd has provided investors with an update on its corporate activities, including its moves to capitalize on the renewed interest in PCR more_horizontal

New York, NY, and Tel Aviv, ISRAEL, Dec. 06, 2022 (GLOBE NEWSWIRE) -- via  NewMediaWire   --   Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive more_horizontal

NEW YORK, NY, AND TEL AVIV, ISRAEL, Nov. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical more_horizontal

Todos Medical Ltd. (OTCQB:TOMDF) has said its Atlanta-area clinical laboratory, Provista Diagnostics Inc, is expanding its onsite school sample colle more_horizontal

Todos Medical Ltd has announced that it's Atlanta-area CLIA/CAP-certified clinical laboratory Provista Diagnostics Inc is now offering saliva-only M more_horizontal

Todos Medical Ltd. (OTCQB:TOMDF) has reported its financial results for the second quarter of 2022 ended June 30, 2022, showing an increase in revenue more_horizontal